{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04709601",
            "orgStudyIdInfo": {
                "id": "STU-2020-0725"
            },
            "organization": {
                "fullName": "University of Texas Southwestern Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex\u2122) in Women With Recurring Urinary Tract Infections.",
            "officialTitle": "Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex\u2122) in the Management of Recurrent Urinary Tract Infections in Women",
            "therapeuticArea": [
                "Infectious Diseases"
            ],
            "study": "efficacy-and-mechanism-of-action-of-methenamine-hippurate-hiprex-in-women-with-recurring-urinary-tract-infections"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-01-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-12-17",
            "studyFirstSubmitQcDate": "2021-01-12",
            "studyFirstPostDateStruct": {
                "date": "2021-01-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Philippe Zimmern",
                "investigatorTitle": "Professor of Urology",
                "investigatorAffiliation": "University of Texas Southwestern Medical Center"
            },
            "leadSponsor": {
                "name": "University of Texas Southwestern Medical Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to measure the concentration of formaldehyde in the urine of women with recurrent urinary tract infections on Hiprex; and then, assuming its urinary presence is confirmed at the proper acid urinary pH, evaluate if such a therapy has favorable effects in decreasing the rate of recurrent urinary tract infections over time."
        },
        "conditionsModule": {
            "conditions": [
                "Urinary Tract Infections"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Group 1 - Patients with negative and positive urine culture",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Hiprex"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Hiprex",
                    "description": "Patients with negative urine culture will be prescribed Hiprex 1 g PO BID x 1 yr and patients with a positive urine culture will be prescribed antibiotics.",
                    "armGroupLabels": [
                        "Group 1 - Patients with negative and positive urine culture"
                    ],
                    "otherNames": [
                        "Methenanime hippurate"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Urinary Tract Infections",
                    "description": "It would be measured by counting the positive urine cultures, or UTI-like episodes requiring antibiotic treatment during the 1 year of the study period.",
                    "timeFrame": "1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of oral anti-biotic usage",
                    "description": "Number of oral-antibiotics use to treat symptomatic UTI episodes",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Number of hospital re-admissions",
                    "description": "Number of hospitalizations due to urosepsis and pyelonephritis",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Number of adverse events related to Hiprex",
                    "description": "Number of participants who experience adverse events \\>= Grade 3, as defined by Common Terminology Criteria for Adverse Events by CTCA version 5.0",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Urine acidity levels",
                    "description": "Urine acidity levels will be measured by urinary pH at each visit.",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Number of urinary tract infection episodes",
                    "description": "Diagnose of UTI will be measured for this outcome",
                    "timeFrame": "up to 2 years"
                },
                {
                    "measure": "Severity of UTI symptoms as measured by the UTI Symptom Assessment questionnaire",
                    "description": "UTI Symptom Assessment questionnaire measures severity of UTI symptoms. Possible score range from 0 to 3 (0= Did not have 1= Mild 2=Moderate, and 3=Severe), higher score indicates higher severity of UTI symptoms",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Duration of intervals between UTI episodes",
                    "description": "Duration of intervals will be measured between one UTI episode to the next UTI episode",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female\n2. Age 50 - 85\n3. Have RUTIs (at least 2 UTIs within the past 6 months or 3 within the past year) -\n\nExclusion Criteria:\n\n1. Being on antibiotics at baseline (i.e. suppressive therapy or antibiotic therapy for urinary or non-urinary infections)\n2. Neurogenic bladder condition\n3. Using urinary catheters (including Foley catheter, intermittent catheterization, and suprapubic catheter)\n4. Uncontrolled diabetes (HbA1c \\> 9)\n5. Chronic renal failure defined as serum creatinine \\> 1.5 mg/dL\n6. History of liver disease\n7. Patients from out of town, in whom follow-up will not be possible\n8. Pregnancy\n9. Allergy to Hiprex\n10. Inability to take Hiprex reliably at home, such as having psychosis, dementia, or swallowing disorders\n11. Non-English speakers -",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "50 Years",
            "maximumAge": "85 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Philippe Zimmern, MD",
                    "role": "CONTACT",
                    "phone": "214/645-8787",
                    "email": "Philippe.Zimmern@UTSouthwestern.edu"
                },
                {
                    "name": "Sonobia Garrett",
                    "role": "CONTACT",
                    "phone": "214/645-8482",
                    "email": "Sonobia.Garrett@UTSouthwestern.edu"
                }
            ],
            "locations": [
                {
                    "facility": "UT-Southwestern Medical Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000014552",
                    "term": "Urinary Tract Infections"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14850",
                    "name": "Recurrence",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17302",
                    "name": "Urinary Tract Infections",
                    "asFound": "Urinary Tract Infections",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4224",
                    "name": "Antibiotics, Antitubercular",
                    "relevance": "LOW"
                },
                {
                    "id": "M11685",
                    "name": "Methenamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M263726",
                    "name": "Methenamine hippurate",
                    "relevance": "LOW"
                },
                {
                    "id": "M263727",
                    "name": "Methenamine mandelate",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}